Dexcom has partnered with recording artist and actor, Nick Jonas, who has Type 1 diabetes, to raise awareness of the benefits of continuous glucose monitoring (CGM) for people with diabetes. Jonas will share his personal story and views on living with diabetes and his use of Dexcom technology to help him monitor his glucose levels and manage his diabetes.
The Type 1 Diabetes Program of The Leona M. and Harry B. Helmsley Charitable Trust has announced the launch of the Diabetes Data Innovation Initiative through which it will provide up to $5 million in funding over the next two years. The funding will go to innovative solutions that enable the use of data to ease the burden of type 1 diabetes (T1D) for those living with the disease, their caregivers and healthcare providers.
Stacey Simms is an award-winning broadcaster and speaker. She is the host of the new podcast, Diabetes Connections, and has blogged since 2007 about her family’s experience with type 1 diabetes.
Asante Solutions announced that it is ceasing all business operations and will no longer sell or support the Asante Snap Insulin Pump. This means all current Asante Snap Insulin Pump users will soon need to transition to a new insulin pump.
The U.S. Food and Drug Administration (FDA) approved Becton Dickinson Medical's (BD) application to begin production of its novel FlowSmart insulin infusion set, designed to improve insulin delivery with less pain. The FlowSmart insulin infusion set was developed in collaboration with JDRF and the Helmsley Charitable Trust.
Karen Graffeo was diagnosed with Type 1 diabetes in 1979, at the age of 11. In 2008 Karen started her diabetes blog, Bitter-Sweet, and became immersed in the Diabetes Online Community. She also advocates offline and is involved with two JDRF chapters in her home state of Connecticut. Karen is hosting the sixth annual Diabetes Blog Week from May 11th – May 17th.
What’s incredibly crunchy, low-carb, nutritious, and a fantastic vehicle for hummus or vegetable dip? Sugar Snap Peas! Despite their name, they’re a refreshing, healthy versatile choice for people with (or without) diabetes.
The European Commission has granted Sanofi marketing authorization in Europe for Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), for the treatment of type 1 and type 2 diabetes mellitus in adults. Toujeo is a next-generation, once-daily basal insulin based on a broadly-used molecule (insulin glargine) with a well-established benefit-risk profile.
It’s a relatively small thing, but it can be a literal lifesaver: medical alert jewelry. For people living with diabetes (or allergies, or asthma, or any other chronic condition), a simple bracelet or necklace can reveal medical information when it’s most important. And there are thousands of options for medical jewelry – from the standard stainless-steel oval-and-chain bracelet to gold cuffs. So how do you choose one?
When you’re living with the everyday ups and downs of blood glucose and medication levels, it can be easy to focus on the immediate consequences of your management efforts – and eventually lose sight of the big blood sugar picture.